Search

Your search keyword '"Massie, Barry M."' showing total 26 results
Start Over Author "Massie, Barry M." Journal circulation
26 results on '"Massie, Barry M."'

2. Response to Letters Regarding Article, “Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction”

Author

Zile, Michael R., primary, Baicu, Catalin F., additional, Gottdiener, John S., additional, Hetzel, Scott J., additional, McMurray, John J., additional, Komajda, Michel, additional, McKelvie, Robert, additional, Massie, Barry M., additional, and Carson, Peter E., additional

Published
2012
Full Text
View/download PDF

4. Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction

Author

Zile, Michael R., primary, Gaasch, William H., additional, Anand, Inder S., additional, Haass, Markus, additional, Little, William C., additional, Miller, Alan B., additional, Lopez-Sendon, Jose, additional, Teerlink, John R., additional, White, Michel, additional, McMurray, John J., additional, Komajda, Michel, additional, McKelvie, Robert, additional, Ptaszynska, Agata, additional, Hetzel, Scott J., additional, Massie, Barry M., additional, and Carson, Peter E., additional

Published
2010
Full Text
View/download PDF

5. Response to Letter Regarding Article, “Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial”

Author

Massie, Barry M., primary, Ammon, Susan E., additional, Collins, Joseph F., additional, Krol, William F., additional, Armstrong, Paul W., additional, Cleland, John G.F., additional, Ezekowitz, Michael, additional, Jafri, Syed M., additional, O'Connor, Christopher M., additional, Schulman, Kevin A., additional, Teo, Koon, additional, and Warren, Stuart, additional

Published
2009
Full Text
View/download PDF

6. Response to Letter Regarding Article, “Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial”

Author

Davis, Barry R., primary, Simpson, Lara M., additional, Ford, Charles E., additional, Kostis, John B., additional, Black, Henry R., additional, Cushman, William C., additional, Einhorn, Paula T., additional, Farber, Michael A., additional, Levy, Daniel, additional, Massie, Barry M., additional, and Nawaz, Shah, additional

Published
2009
Full Text
View/download PDF

7. Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure

Author

Massie, Barry M., primary, Collins, Joseph F., additional, Ammon, Susan E., additional, Armstrong, Paul W., additional, Cleland, John G.F., additional, Ezekowitz, Michael, additional, Jafri, Syed M., additional, Krol, William F., additional, O'Connor, Christopher M., additional, Schulman, Kevin A., additional, Teo, Koon, additional, and Warren, Stuart R., additional

Published
2009
Full Text
View/download PDF

8. Prevention of Atrial Fibrillation

Author

Benjamin, Emelia J., primary, Chen, Peng-Sheng, additional, Bild, Diane E., additional, Mascette, Alice M., additional, Albert, Christine M., additional, Alonso, Alvaro, additional, Calkins, Hugh, additional, Connolly, Stuart J., additional, Curtis, Anne B., additional, Darbar, Dawood, additional, Ellinor, Patrick T., additional, Go, Alan S., additional, Goldschlager, Nora F., additional, Heckbert, Susan R., additional, Jalife, José, additional, Kerr, Charles R., additional, Levy, Daniel, additional, Lloyd-Jones, Donald M., additional, Massie, Barry M., additional, Nattel, Stanley, additional, Olgin, Jeffrey E., additional, Packer, Douglas L., additional, Po, Sunny S., additional, Tsang, Teresa S.M., additional, Van Wagoner, David R., additional, Waldo, Albert L., additional, and Wyse, D. George, additional

Published
2009
Full Text
View/download PDF

9. Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Author

Davis, Barry R., primary, Kostis, John B., additional, Simpson, Lara M., additional, Black, Henry R., additional, Cushman, William C., additional, Einhorn, Paula T., additional, Farber, Michael A., additional, Ford, Charles E., additional, Levy, Daniel, additional, Massie, Barry M., additional, and Nawaz, Shah, additional

Published
2008
Full Text
View/download PDF

10. Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia

Author

Ghali, Jalal K., primary, Anand, Inder S., additional, Abraham, William T., additional, Fonarow, Gregg C., additional, Greenberg, Barry, additional, Krum, Henry, additional, Massie, Barry M., additional, Wasserman, Scott M., additional, Trotman, Marie-Louise, additional, Sun, Yan, additional, Knusel, Beat, additional, and Armstrong, Paul, additional

Published
2008
Full Text
View/download PDF

11. Abstract 3640: Diabetes Mellitus is Associated with Increased Risk of Fatal and Non-Fatal Cardiovascular Events in Heart Failure Patients with Preserved Ejection Fraction - Findings From the Irbesartan in Heart Failure with Preserved Systolic Function Trial

Author

McKelvie, Robert S, primary, Komajda, Michel, additional, Massie, Barry M, additional, McMurray, John J, additional, Zile, Michael R, additional, Donovan, Mark, additional, Ptaszynska, Agata, additional, and Carson, Peter, additional

Published
2007
Full Text
View/download PDF

12. Abstract 3148: Atrial Fibrillation Is Associated With Increased Risk Of Fatal And Non-fatal Cardiovascular Events In Patients With Heart Failure And Preserved Ejection Fraction - Findings From The Irbesartan In Heart Failure With Preserved Systolic Function Trial (I-PRESERVE)

Author

Zile, Michael R, primary, Komajda, Michel, additional, McKelvie, Robert, additional, McMurray, John, additional, Donovan, Mark, additional, Ptaszynska, Agata, additional, Carson, Peter, additional, and Massie, Barry M, additional

Published
2007
Full Text
View/download PDF

13. Response to Letter Regarding Article, “Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study”

Author

Go, Alan S., primary, Yang, Jingrong, additional, Ackerson, Lynn M., additional, Lepper, Krista, additional, Shlipak, Michael G., additional, Robbins, Sean, additional, and Massie, Barry M., additional

Published
2007
Full Text
View/download PDF

15. Acute Heart Failure Syndromes

Author

Gheorghiade, Mihai, primary, Zannad, Faiez, additional, Sopko, George, additional, Klein, Liviu, additional, Piña, Ileana L., additional, Konstam, Marvin A., additional, Massie, Barry M., additional, Roland, Edmond, additional, Targum, Shari, additional, Collins, Sean P., additional, Filippatos, Gerasimos, additional, and Tavazzi, Luigi, additional

Published
2005
Full Text
View/download PDF

18. Improving Guideline Adherence

Author

Ansari, Maria, primary, Shlipak, Michael G., additional, Heidenreich, Paul A., additional, Van Ostaeyen, Denise, additional, Pohl, Elizabeth C., additional, Browner, Warren S., additional, and Massie, Barry M., additional

Published
2003
Full Text
View/download PDF

25. Long-Term Follow-Up of Participants With Heart Failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Author

Piller, Linda B., Baraniuk, Sarah, Simpson, Lara M., Cushman, William C., Massie, Barry M., Einhorn, Paula T., Oparil, Suzanne, Ford, Charle E., Graurnlich, James F., Dart, Richard A., Parish, David C., Retta, Tarnrat M., Cuyjet, Aloysius B., Jafri, Syed Z., Furberg, Curt D., Saklayen, Mohammad G., Thadani, Udho, Probstfield, Jeffrey L., and Davis, Barry R.

Published
2011
Full Text
View/download PDF

26. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure.

Author

Ansari M, Shlipak MG, Heidenreich PA, Van Ostaeyen D, Pohl EC, Browner WS, and Massie BM

Subjects
Cohort Studies, Health Personnel education, Health Personnel standards, Humans, Information Dissemination, Nurse Practitioners standards, Patient Education as Topic methods, Patient Education as Topic standards, Reminder Systems, Adrenergic beta-Antagonists therapeutic use, Drug Utilization statistics & numerical data, Guideline Adherence statistics & numerical data, Heart Failure drug therapy, Outcome and Process Assessment, Health Care statistics & numerical data, Practice Patterns, Physicians' statistics & numerical data
Abstract

Background: The dissemination of clinical practice guidelines often has not been accompanied by desired improvements in guideline adherence. This study evaluated interventions for implementing a new practice guideline advocating the use of beta-blockers for heart failure patients., Methods and Results: This was a randomized controlled trial involving heart failure patients (n=169) with an ejection fraction < or =45% and no contraindications to beta-blockers. Patients' primary providers were randomized in a stratified design to 1 of 3 interventions: (1) control: provider education; (2) provider and patient notification: computerized provider reminders and patient letters advocating beta-blockers; and (3) nurse facilitator: supervised nurse to initiate and titrate beta-blockers. The primary outcome, the proportion of patients who were initiated or uptitrated and maintained on beta-blockers, analyzed by intention to treat, was achieved in 67% (36 of 54) of patients in the nurse facilitator group compared with 16% (10 of 64) in the provider/patient notification and 27% (14 of 51) in the control groups (P<0.001 for the comparisons between the nurse facilitator group and both other groups). The proportion of patients on target beta-blocker doses at the study end (median follow-up, 12 months) was also highest in the nurse facilitator group (43%) compared with the control (10%) and provider/patient notification groups (2%) (P<0.001). There were no differences in adverse events among groups., Conclusions: The use of a nurse facilitator was a successful approach for implementing a beta-blocker guideline in heart failure patients. The use of provider education, clinical reminders, and patient education was of limited value in this setting.

Published
2003
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results